Literature DB >> 6611437

Efficacy of streptococcal preparation OK-432 for gastric cancer patients--comparison between intradermal and intramuscular injection.

H Hanaue, T Kurosawa, S Yoshizaki, J Shikata.   

Abstract

Nonspecific immunotherapy with OK-432, penicillin and heat treated lyophilized powder of Su-strain of streptococcus pyogens A3, was evaluated in patients with recurrent or unresectable stomach cancer to assess the relative benefit of the preparation administered by different routes. Comparative studies were made of the variation in immunological parameters, the survival rate and the incidence of adverse reactions in two groups of patients with uniform background factors: 24 receiving the preparation intradermally and 18 receiving intramuscular doses of the preparation. In for former group, no serious adverse reaction occurred but more marked improvement was achieved in various immunological parameters examined. The survival rate was significantly higher (P = 0.005) for patients receiving intradermal than those receiving intramuscular doses of the preparation. The results of the present study showed that the preparation is of greater value when it is administered intradermally than intramuscularly.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611437     DOI: 10.1007/bf02469567

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  13 in total

1.  Thymosin immunotherapy in patients with small cell carcinoma of the lung: correlation of in vitro studies with clinical course.

Authors:  S D Lipson; P B Chretien; R Makuch; D E Kenady; M H Cohen
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

2.  Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer.

Authors:  W K Amery
Journal:  Cancer Treat Rep       Date:  1978-11

Review 3.  Possibilities and problems of immunologic intervention in cancer.

Authors:  R T Smith
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

Review 4.  Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci.

Authors:  H Okamoto; S Shoin; S Koshimura; R Shimizu
Journal:  Jpn J Microbiol       Date:  1967-12

5.  Impaired immunologic reactivity and recurrence following cancer surgery.

Authors:  F R Eilber; D L Morton
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

6.  Response to BCG vaccination and survival in advanced Hodgkin's disease.

Authors:  J E Sokal; C W Aungst
Journal:  Cancer       Date:  1969-07       Impact factor: 6.860

7.  Re-evaluation of immunological parameters in immunotherapy for advanced carcinoma of the digestive tract.

Authors:  H Hanaue; S Yoshizaki; T Kurosawa
Journal:  Gastroenterol Jpn       Date:  1983-08

8.  Preoperative cell-mediated immune status of gastric cancer patients.

Authors:  K Orita; H Miwa; H Fukuda; M Yumura; Y Uchida
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

9.  Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro.

Authors:  A Uchida; T Hoshino
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

Review 10.  Immunochemotherapy in 34 cases of oat cell carcinoma of the lung with 19 complete responses.

Authors:  L Israël; A Depierre; C Choffel; B Milleron; R Edelstein
Journal:  Cancer Treat Rep       Date:  1977 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.